Literature DB >> 21327836

Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.

Tahuanty A Pena1, Ayman O Soubani, Lobelia Samavati.   

Abstract

Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. Pulmonary sarcoidosis, a granulomatous inflammatory disorder, is associated with CCPA. We identified CCPA in 2% of cases in a large cohort of sarcoidosis patients. We found a lack of response to medical treatment and poor outcome in this subgroup.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21327836     DOI： 10.1007/s00408-011-9280-9

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


  40 in total

Review 1.  Interferon-induced granulomatous lung disease.

Authors:  Kamel Marzouk; Samer Saleh; Mouhamed Kannass; Om P Sharma
Journal:  Curr Opin Pulm Med       Date:  2004-09       Impact factor: 3.155

Review 2.  [Pulmonary consequences of marijuana smoking].

Authors:  Andreas Klaus Pfeifer; Peter Lange
Journal:  Ugeskr Laeger       Date:  2006-05-01

3.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

4.  Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.

Authors:  F Idali; M Wikén; J Wahlström; H Mellstedt; A Eklund; H Rabbani; J Grunewald
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

5.  Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.

Authors:  Juliette Camuset; Hilario Nunes; Marie-Christine Dombret; Anne Bergeron; Priscilla Henno; Bruno Philippe; Gaelle Dauriat; Gilles Mangiapan; Antoine Rabbat; Jacques Cadranel
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

6.  Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis.

Authors:  S Centeno-Lima; J M de Lacerda; J A do Carmo; M Abecasis; C Casimiro; F Exposto
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Surgical outcome of pulmonary aspergilloma.

Authors:  Alaa Brik; Abdel Meged Salem; Al Rady Kamal; Mohamed Abdel-Sadek; Mohamed Essa; Mamdoh El Sharawy; Ahmed Deebes; Khaled Abdel Bary
Journal:  Eur J Cardiothorac Surg       Date:  2008-08-12       Impact factor: 4.191

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B.

Authors:  K S Lee; H T Kim; Y H Kim; K O Choe
Journal:  AJR Am J Roentgenol       Date:  1993-10       Impact factor: 3.959

10.  Aspergillomas complicating sarcoidosis. A prospective study in 100 patients.

Authors:  C Wollschlager; F Khan
Journal:  Chest       Date:  1984-10       Impact factor: 9.410
View more
  10 in total

1.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

Review 2.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 3.  Lung transplantation for pulmonary sarcoidosis.

Authors:  Keith C Meyer
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 4.  Imaging aspects of the diagnosis of sarcoidosis.

Authors:  Paolo Spagnolo; Nicola Sverzellati; Athol U Wells; David M Hansell
Journal:  Eur Radiol       Date:  2014-01-08       Impact factor: 5.315

Review 5.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 6.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

7.  Cavitary alveolar sarcoidosis complicated by an aspergilloma.

Authors:  Kamal Gera; Chandramani Panjabi; Devijyoti Dash; Ashok Shah
Journal:  BMJ Case Rep       Date:  2014-10-17

8.  Fungal infection mimicking pulmonary malignancy: clinical and radiological characteristics.

Authors:  Marcos Duarte Guimarães; Edson Marchiori; Gustavo de Souza Portes Meirelles; Bruno Hochhegger; Pablo Rydz Pinheiro Santana; Jefferson Luiz Gross; Almir Galvão Vieira Bitencourt; Piyaporn Boonsirikamchai; Myrna Corbos Barco Godoy
Journal:  Lung       Date:  2013-09-17       Impact factor: 2.584

9.  Central Nervous System Cryptococcosis in Patients With Sarcoidosis: Comparison With Non-sarcoidosis Patients and Review of Potential Pathophysiological Mechanisms.

Authors:  Renaud Prevel; Vivien Guillotin; Sébastien Imbert; Patrick Blanco; Laurence Delhaes; Pierre Duffau
Journal:  Front Med (Lausanne)       Date:  2022-03-29

Review 10.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.